OOIR: Observatory of International Research

Papers

(The H4-Index of Journal of Controlled Release is 89. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-10-01 to 2024-10-01.)

Article	Citations
Polymeric micelles in drug delivery: An insight of the techniques for their characterization and assessment in biorelevant conditions	556
Nanomaterials-based photothermal therapy and its potentials in antibacterial treatment	420
Electrospinning for drug delivery applications: A review	413
Polymeric micelles in cancer therapy: State of the art	332
The dawn of mRNA vaccines: The COVID-19 case	313
Controlled anti-cancer drug release through advanced nano-drug delivery systems: Static and dynamic targeting strategies	302
Chitosan hydrogels for sustained drug delivery	278
Delivering the power of nanomedicine to patients today	247
Surface functionalization of exosomes for target-specific delivery and in vivo imaging & tracking: Strategies and significance	241
Nanoparticles in sustainable agriculture: An emerging opportunity	234
Exosomes: Large-scale production, isolation, drug loading efficiency, and biodistribution and uptake	226
Vat photopolymerization 3D printing for advanced drug delivery and medical device applications	223
Controlled release fertilizer: A review on developments, applications and potential in agriculture	221
Semi-solid extrusion 3D printing in drug delivery and biomedicine: Personalised solutions for healthcare challenges	196
Evolution of drug delivery systems: From 1950 to 2020 and beyond	192
Impact of lipid nanoparticle size on mRNA vaccine immunogenicity	192
Chronic wounds: Current status, available strategies and emerging therapeutic solutions	188
Challenges in the development and establishment of exosome-based drug delivery systems	187
The role of natural polymers in bone tissue engineering	179
Recent advances in polymeric transdermal drug delivery systems	176
A review of nanotechnology-based approaches for breast cancer and triple-negative breast cancer	174
Zero-order drug delivery: State of the art and future prospects	173
A spatiotemporal release platform based on pH/ROS stimuli-responsive hydrogel in wound repairing	163
Preparation and application of pH-responsive drug delivery systems	163
Advanced drug delivery applications of layered double hydroxide	163

Agarose-based biomaterials for advanced drug delivery	162
Stimuli-responsive In situ gelling system for nose-to-brain drug delivery	161
Hyaluronic acid and albumin based nanoparticles for drug delivery	159
Non-viral vectors for RNA delivery	157
Charge-reversal biodegradable MSNs for tumor synergetic chemo/photothermal and visualized therapy	157
Ultrasound and microbubble mediated therapeutic delivery: Underlying mechanisms and future outlook	157
Cell membrane coated nanocarriers - an efficient biomimetic platform for targeted therapy	154
Advances in biodegradable and injectable hydrogels for biomedical applications	150
Recent trends in organic coating based on biopolymers and biomass for controlled and slow release fertilizers	149
Aerogels in drug delivery: From design to application	149
Metal-doped and hybrid carbon dots: A comprehensive review on their synthesis and biomedical applications	145
Microneedles for painless transdermal immunotherapeutic applications	142
Dissolving microneedles: Applications and growing therapeutic potential	141
Overcoming skin barriers through advanced transdermal drug delivery approaches	139
Microfluidic technologies and devices for lipid nanoparticle-based RNA delivery	138
Nanomedicines accessible in the market for clinical interventions	137
Magnetic nanoparticles coated with polyphenols for spatio-temporally controlled cancer photothermal/immunotherapy	136
Recent advances in nanoparticle-based photothermal therapy for breast cancer	133
Actively targeted nanomedicines for precision cancer therapy: Concept, construction, challenges and clinical translation	127
The replacement of helper lipids with charged alternatives in lipid nanoparticles facilitates targeted mRNA delivery to the spleen and lungs	126
Polyethylene glycol (PEG): The nature, immunogenicity, and role in the hypersensitivity of PEGylated products	125
Solid lipid nanoparticles for hydrophilic drugs	125
Rational design of a minimalist nanoplatform to maximize immunotherapeutic efficacy: Four birds with one stone	124
Circular RNA: An emerging frontier in RNA therapeutic targets, RNA therapeutics, and mRNA vaccines	120
Smart biomimetic metal organic frameworks based on ROS-ferroptosis-glycolysis regulation for enhanced tumor chemo-immunotherapy	119
Strategies to improve the EPR effect: A mechanistic perspective and clinical translation	119
Bioresponsive drug delivery systems for the treatment of inflammatory diseases	117
M2-type exosomes nanoparticles for rheumatoid arthritis therapy via macrophage re-polarization	117
Customizing nano-chitosan for sustainable drug delivery	116
Carrier-free nanodrugs for safe and effective cancer treatment	116
Neurodegenerative diseases and effective drug delivery: A review of challenges and novel therapeutics	115
Delivery of CRISPR-Cas tools for in vivo genome editing therapy: Trends and challenges	112
Serum protein-based nanoparticles for cancer diagnosis and treatment	111
Thiolated polymeric hydrogels for biomedical application: Cross-linking mechanisms	108
Fused Deposition Modeling (FDM), the new asset for the production of tailored medicines	108
In vitro models replicating the human intestinal epithelium for absorption and metabolism studies: A systematic review	108
Magnetic nanoparticles for cancer theranostics: Advances and prospects	108
Intratumoral delivery of IL-12 and IL-27 mRNA using lipid nanoparticles for cancer immunotherapy	106
Machine learning predicts 3D printing performance of over 900 drug delivery systems	106
Polymeric delivery systems for nucleic acid therapeutics: Approaching the clinic	106
Progress in the design and development of “fast-dissolving” electrospun nanofibers based drug delivery systems - A systematic review	105
Bacteria and bacterial derivatives as drug carriers for cancer therapy	104
Hybrid exosomes, exosome-like nanovesicles and engineered exosomes for therapeutic applications	104
PCL-PEG copolymer based injectable thermosensitive hydrogels	103
Biofilm microenvironment activated supramolecular nanoparticles for enhanced photodynamic therapy of bacterial keratitis	102
Multifunctional ginsenoside Rg3-based liposomes for glioma targeting therapy	100
Cell penetrating peptides: A versatile vector for co-delivery of drug and genes in cancer	100
Computational pharmaceutics - A new paradigm of drug delivery	99
Recent advances and remaining barriers to producing novel formulations of fungicides for safe and sustainable agriculture	98
Injectable thermoresponsive hydrogels as drug delivery system for the treatment of central nervous system disorders: A review	97

Current trends in smart mesoporous silica-based nanovehicles for photoactivated cancer therapy	97
Recent advances of redox-responsive nanoplatforms for tumor theranostics	97
Stealth nanoparticles in oncology: Facing the PEG dilemma	96
Magnetic-responsive hydrogels: From strategic design to biomedical applications	96
Heterojunction engineered bioactive chlorella for cascade promoted cancer therapy	96
Recent advances in colon drug delivery systems	94
Polymeric microneedle-mediated transdermal delivery of melittin for rheumatoid arthritis treatment	92
Tendon tissue engineering: Cells, growth factors, scaffolds and production techniques	92
Intravitreal hydrogels for sustained release of therapeutic proteins	92
Nanomaterials applied in wound healing: Mechanisms, limitations and perspectives	90
Multifunctional graphene oxide nanoparticles for drug delivery in cancer	90
Stimuli-responsive liposomal nanoformulations in cancer therapy: Pre-clinical & clinical approaches	90
Peptide-functionalized liposomes as therapeutic and diagnostic tools for cancer treatment	89
Recent trends, challenges and future outlook of transdermal drug delivery systems for rheumatoid arthritis therapy	89